ASH CLOUD

Developing the enteric methane inhibitor Bovaer® over the last 16 years with Maik Kindermann - DSM-Firmenich

May 30, 2024 Ash Sweeting Season 1 Episode 42
Developing the enteric methane inhibitor Bovaer® over the last 16 years with Maik Kindermann - DSM-Firmenich
ASH CLOUD
More Info
ASH CLOUD
Developing the enteric methane inhibitor Bovaer® over the last 16 years with Maik Kindermann - DSM-Firmenich
May 30, 2024 Season 1 Episode 42
Ash Sweeting

Maik Kindermann, the inventor of the methane inhibitor 3-NOP or  Bovaer®. Earlier this week it was announced that Boaver has been approved for use by the FDA adding the United States to the other 59 countries where its available. Following a directive in 2008 from Feike Sifbesma, the former Chairman and CEO of dsm-firmenich Maik began working on a product to inhibit enteric methane. 16 years later Maik and his team have completed trials 119  and published 80 peer reviewed papers with another 31 in the pipeline. I recently caught up with Maik to hear about his journey developing Boaver and how the conversation on enteric methane has changed over that time. 

You can listen too our conversation here.

Show Notes

Maik Kindermann, the inventor of the methane inhibitor 3-NOP or  Bovaer®. Earlier this week it was announced that Boaver has been approved for use by the FDA adding the United States to the other 59 countries where its available. Following a directive in 2008 from Feike Sifbesma, the former Chairman and CEO of dsm-firmenich Maik began working on a product to inhibit enteric methane. 16 years later Maik and his team have completed trials 119  and published 80 peer reviewed papers with another 31 in the pipeline. I recently caught up with Maik to hear about his journey developing Boaver and how the conversation on enteric methane has changed over that time. 

You can listen too our conversation here.